• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
CONCLUSIONS: The current status of the utilization of OACs in Middle Eastern AF patients appears to be promising and is consistent with the 2019 focused update of the 2014 AHA/ACC/HRS guideline. This trial is registered with NCT03917992.PMID:33898065 | PMC:PMC8052172 | DOI:10.1155/2021/5515089
Source: International Journal of Vascular Medicine - April 26, 2021 Category: Cardiology Authors: Ayman J Hammoudeh Yousef Khader Nazih Kadri Eyas Al-Mousa Yahya Badaineh Laith Habahbeh Ramzi Tabbalat Hesham Janabi Imad A Alhaddad Source Type: research

Pharmacotherapy for Patients With Atrial Fibrillation and Cerebral Microbleeds
Background: Patients with cerebral microbleeds have increased risk of intracranial hemorrhage and ischemic stroke. No trial specifically informs antithrombotic therapy for patients with cerebral microbleeds and atrial fibrillation. We investigated the safety of anticoagulation versus no anticoagulation with regard to cerebrovascular outcomes and mortality. Methods: All consecutive atrial fibrillation patients from 2015 to 2018 with MRI evidence of ≥1 cerebral microbleed at time of imaging were reviewed.
Source: Journal of Stroke and Cerebrovascular Diseases - May 14, 2019 Category: Neurology Authors: Mohammed K. Badi, George K. Vilanilam, Vivek Gupta, Kevin M. Barrett, Elizabeth R. Lesser, Jordan J. Cochuyt, David O. Hodge, Thomas G. Brott, James F. Meschia Source Type: research

Pages: 1  2  3  4  5  6